Sign in

You're signed outSign in or to get full access.

Anthony Brian Goodman

Chief Executive Officer at Golden Matrix Group
CEO
Executive
Board

About Anthony Brian Goodman

Anthony Brian “Brian” Goodman (age 66) is President, CEO, Secretary, Treasurer, and Director of Golden Matrix Group (GMGI); he has served as CEO and director since February 2016 and was Chairman until April 2024 . He is a qualified pharmacist (BPharm, University of the Witwatersrand, 1981; re-qualified in Australia in 1989) and has 30+ years of senior operating experience in gaming and technology businesses . Under GMGI’s current structure (MeridianBet as accounting acquirer), FY 2024 revenue was $151.1M (+63% YoY), with Q4 2024 revenue up 81% to $46M; Adjusted EBITDA for 2024 was $22.19M (+4% YoY) and Q4 2024 Adjusted EBITDA $6.54M (+69% YoY) . Company cumulative TSR values used in pay-versus-performance reporting were $39.56 (2022), $37.54 (2023), and $30.84 (2024) per $100 initial investment, consistent with a challenging market backdrop during 2024 .

Past Roles

OrganizationRoleYearsStrategic impact
Golden Matrix Group (GMGI)CEO; Chairman (through Apr 2024); DirectorCEO/Director since Feb 2016; Chairman until Apr 2024Led expansion, M&A (MeridianBet), and platform growth; transitioned Board chair role to independent chair in 2024 .
Articulate Pty Ltd (Australia)Managing Director (founder)Since Jan 1990Tech/customer support services; historical licensed use of GM2 Asset in East Asia under a license terminated Jan 1, 2025 .
Elray Resources Inc. (OTC: ELRA)CEO & DirectorSince Feb 23, 2011Blockchain/online casino licensee of GMGI content; related-party license with GMGI; modest revenue contribution .
Luxor Capital LLCManaging MemberSince Oct 2015Vehicle holding GMGI shares attributed to Goodman’s beneficial ownership .
Global Technology Group Pty LtdManaging DirectorSince Sep 2019GMGI subsidiary leadership role .
Classics Holdings Co. Pty LimitedDirectorSince Aug 2024GMGI owns 100%; supports B2C raffles growth (Classics for a Cause) .
Allergan Pharmaceuticals (South Africa)VP Marketing & Sales1982–1984Pharma commercial leadership .
Daelite Pharmacy GroupOwner/Operator1984–1990Retail operations leadership .

External Roles

OrganizationRoleYearsNotes
Elray Resources Inc. (OTC: ELRA)CEO & DirectorSince 2011Related-party license; Board/Audit Committee approved; Goodman abstained .
Classics Holdings Co. Pty LimitedDirectorSince 2024GMGI wholly-owned; directors oversee B2C initiatives .

Fixed Compensation

MetricFY2023Stub 2023 (Nov 1–Dec 31, 2023)FY2024
Base salary ($)161,040 29,040 303,600
Stock awards ($ fair value)
All other compensation ($)17,186 (superannuation) 3,194 34,386
Total ($)178,226 32,234 337,986
  • Contracted salary steps: $158,400 (Oct 26, 2020 start), $174,240 effective Sep 1, 2023; $396,000 effective Jun 18, 2024; $435,600 effective Sep 1, 2025; Australian superannuation escalated to 12% by Jun 30, 2025 .
  • Term through Aug 20, 2027; auto-renews annually unless notice 3 months prior .

Performance Compensation

Metric/InstrumentWeightingTarget DefinitionActualPayoutVesting terms
2024 RSUs (250,000 units)50% Revenue; 50% Adjusted EBITDA FY2024 Revenue and Adjusted EBITDA as per audited 10-K Targets met 250,000 RSUs vested; year-end value $495,000 at $1.98/share Vested after public disclosure in 2024 10-K (filed Mar 27, 2025)
CEO “Compensation Actually Paid” (CAP)n/aItem 402(v) method 2022: $2,035,629; 2023: $385,726; 2024: $(155,764) n/an/a

Notes:

  • No executive held option awards as of Dec 31, 2024 (low option overhang) .
  • Company has adopted a Dodd-Frank compliant clawback policy effective Oct 2, 2023 .
  • Insider trading policy discourages hedging and prohibits pledging unless financially able to repay without resort to pledged securities; 10b5-1 plans encouraged .

Equity Ownership & Alignment

HolderCommon shares beneficially owned% of commonSeries B Voting PreferredSeries B votesTotal voting shares% of total voting
Anthony B. Goodman16,874,562 (incl. 7,470,483 via Luxor Capital) 11.9% 1,000 7,500,000 (7,500 votes/share) 23,374,562 15.0%

Additional alignment details:

  • RSUs: 250,000 granted; 2024 performance-based tranches vested post-year-end (supply consideration) .
  • Ownership guidelines: Company currently has no executive equity ownership policy .
  • Anti-hedging/pledging: directors/officers prohibited from derivatives and short sales; pledging only with demonstrable capacity to repay; no pledges disclosed for Goodman .

Employment Terms

  • Term/renewal: Agreement effective Oct 26, 2020; current term through Aug 20, 2027; auto-renewal year-to-year thereafter; terminable by either party with/without cause per contract .
  • Severance (non-CoC): If terminated by Company without cause or by Goodman for good reason: lump-sum equal to 18 months of then-current base salary plus target bonus; pro rata current-year bonus; full accelerated vesting of unvested equity; options exercisable up to one year or original expiry, whichever earlier .
  • Change-of-control: Single-trigger equity acceleration upon a Change of Control (all equity vests regardless of continued employment); cash severance of 3.0x (base + most recent bonus) upon CoC termination or in anticipation thereof (within six months prior), less any prior severance paid .
  • Restrictive covenants: 1-year non-compete post-termination in US/UK gaming-related businesses; confidentiality and IP assignment; standard non-solicitation .
  • Outside activities: Agreement does not restrict services to Luxor Capital, Elray Resources, or Articulate (reflecting disclosed related-party roles) .

Board Governance

  • Current roles: Director since Feb 2016; not serving on Audit, Compensation, or Nominating & Governance committees (those are fully independent) .
  • Board structure: Independent Chairman (William Scott) with CEO/Chair roles split; Board cites this as effective for oversight and management accountability .
  • Committee composition: Audit (Chair: M.G. Smith; members: McChesney, Scott); Compensation (Chair: McChesney; members: Smith); Nominating & Governance (Chair: Scott; member: McChesney) — all independent .
  • Attendance: All directors attended at least 75% of Board and committee meetings in 2024; all directors attended Oct 7, 2024 annual meeting .
  • Controlled-company status: Majority voting power controlled by Meridian Sellers; GMGI voluntarily maintains majority independent Board and independent committees .
  • Voting Agreement: Meridian Sellers agreed not to remove Goodman as CEO (absent cause or fiduciary duty constraints) during the Voting Agreement term; Series C holders appoint two directors .

Performance & Track Record

Metric202220232024
Revenue ($)$92.99M $151.12M (+63% YoY)
Adjusted EBITDA ($)$21.25M $22.19M (+4% YoY)
Q4 Revenue ($)$46M (+81% YoY)
Q4 Adjusted EBITDA ($)$3.88M $6.54M (+69% YoY)
Cumulative TSR ($100 basis)$39.56 $37.54 $30.84
  • Notable achievements: Closed MeridianBet acquisition (reverse merger accounting, MeridianBet as accounting acquirer), expanded into LatAm/Europe, record B2B and B2C performance; guidance for Q1 2025 revenue +69% to +80% YoY ($42–45M) .
  • Disclosed legacy proceeding: 2016 SEC cease-and-desist against Elray (Goodman is CEO of Elray); administrative settlement applied to Elray, not to Goodman individually .

Compensation Structure Analysis

  • Mix shift: 2024 CEO pay largely cash base and statutory superannuation; performance equity tied to 2024 revenue/AEBITDA targets vested after goals met (greater line-of-sight, lower risk than options) .
  • Pay-for-performance link: CAP moved negative in 2024 (due to equity valuation adjustments) even as operational metrics improved, aligning with TSR pressure and higher amortization/interest costs post-M&A .
  • Guarantees vs at-risk: Base escalations are contractually set (min +10% annually), raising fixed pay’s share; however, performance RSUs and clawback policy temper this risk .
  • Equity plan capacity: 2018/2022/2023 plans active; evergreen features; Board reduced 2023 Plan auto-increase in 2025 to limit dilution (3.632M vs 5.0M) .

Related Party Transactions (Governance Red Flags to Monitor)

  • Articulate Pty Ltd (50% owned by Goodman; 50% by spouse): License agreement for GM2 Asset; 2024 revenue $192,807; A/R $313,509 at Dec 31, 2024; license terminated effective Jan 1, 2025; A/R $132,072 at Jun 30, 2025 .
  • Elray Resources Inc. (Goodman CEO/Director; Feng Director): License of GMGI games; 2024 revenue $36,205; A/R $35,911 at Dec 31, 2024; Board and Audit Committee approved with Goodman/Feng abstaining .
  • Family employment: Brett Goodman (son) employed as VP Business Development; compensation terms and equity grants disclosed .
  • Day-to-Day Management Agreement: Limits interference with MeridianBet day-to-day operations through April 2026; coupled with Voting Agreement dynamics; governance complexity warrants monitoring .

Director Service and Compensation (for dual-role implications)

  • Board service: Goodman has been a director since 2016; not independent due to CEO role .
  • Committees: Not a member of Audit/Comp/Nom-Gov (all independent), mitigating CEO influence over pay and oversight .
  • Director pay: Executives are not separately paid for Board service; independent director retainers were increased to $7,500/month effective Jun 1, 2024 .

Equity Ownership & Voting Structure Considerations

  • Goodman’s 1,000 Series B Voting Preferred shares carry 7.5 million votes (7,500 votes/share), increasing total voting power to 15.0% despite 11.9% of common .
  • Series C Preferred (held by Meridian Sellers) carries class voting rights to appoint two directors and significant aggregate voting power; combined with Voting Agreement, this supports management continuity but can reduce minority investor influence .

Say-on-Pay & Shareholder Feedback

  • Say-on-pay frequency set to triennial in 2022; Company is holding an advisory say-on-pay vote at the 2025 annual meeting; the next say-on-pay is expected at the 2028 annual meeting (no historical approval percentages disclosed) .

Expertise & Qualifications

  • Education: BPharm, University of the Witwatersrand (1981); re-qualified pharmacist in Australia (1989) .
  • Industry expertise: Gaming technology, international operations, and entrepreneurial leadership; Board cites his expertise as qualification for director service .

Risk Indicators & Red Flags

  • Single-trigger equity vesting on Change-of-Control (immediate vest regardless of retention) raises potential misalignment risk in transactional scenarios .
  • Related-party dealings (Articulate, Elray) and family employment require continued Audit Committee oversight (policies in place, approvals/abstentions disclosed) .
  • Controlled-company dynamics and Series C appointment rights may entrench governance, though Board maintains majority independence and independent committees .
  • Anti-hedging/pledging policy in place; no pledging disclosed for Goodman (monitor ongoing compliance) .

Investment Implications

  • Alignment: Goodman’s sizable ownership (11.9% common; 15.0% voting) and performance-based RSUs provide meaningful alignment; anti-hedging/pledging policies are shareholder-friendly; absence of ownership guidelines is a gap .
  • Retention and deal incentives: Robust severance (18 months+target bonus) and 3.0x CoC cash multiple with single-trigger equity accelerate retention and potential M&A execution, but increase payout risk in a sale; investors should model CoC economics .
  • Execution track: FY2024 operational metrics improved materially (revenue +63%, Q4 AEBITDA +69%); CEO CAP turned negative in 2024, indicating sensitivity of reported pay to equity valuation and restructuring costs rather than cash increases—a constructive P4P signal .
  • Governance watch items: Related-party transactions (mitigated by independent approvals), Voting Agreement constraints, and Meridian Sellers’ board appointment rights warrant continued monitoring, especially around capital allocation and further M&A .

Appendix: Pay vs Performance (Company disclosure)

Item202220232024
CEO CAP ($)2,035,629 385,726 (155,764)
Avg NEO CAP ($)673,179 276,136 266,611
Company TSR ($100 basis)39.56 37.54 30.84
Net income (loss) ($)(250,038) 13,894,886 (1,409,849)

All citations refer to GMGI’s 2025 Definitive Proxy (DEF 14A) and 2025 current reports on Form 8-K as indicated.